Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Jantoven 2 Mg Tabs 100 By Upsher Smith

Image 0 of Jantoven 2 Mg Tabs 100 By Upsher SmithImage 1 of Jantoven 2 Mg Tabs 100 By Upsher Smith

Jantoven 2 Mg Tabs 100 By Upsher Smith

Call for Price

Jantoven 2 Mg Tabs 100 By Upsher Smith This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXD3524915/RXB10056538
Size : 100
Selling UoM : EA
NDC: 00832-1212-00
UPC Barcode : 308321212004
Supplier: 0050000993 UPSHER-SMITH PHARM
Supplier Material : 121200
Generic Code : 006561 WARFARIN SODIUM ORAL TABLET 2 MG
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product Type : GRX Generic RX

Have a question?

  Call for Price

Product Description.:

WRF 2, 832
tablet , lavender , scored , round round
Flat-faced beveled-edgeDebossed

Jantoven? Tablets (crystalline warfarin sodium) is an anticoagulant which acts by inhibiting vitamin K-dependent coagulation factors. Chemically, it is 3-(α-acetonylbenzyl)-4-hydroxycoumarin and is a racemic mixture of the R- and S-enantiomers. Crystalline warfarin sodium is an isopropanol clathrate. The crystallization of warfarin sodium virtually eliminates trace impurities present in amorphous warfarin.

Crystalline warfarin sodium occurs as a white, odorless, crystalline powder, is discolored by light and is very soluble in water freely soluble in alcohol very slightly soluble in chloroform and in ether.

Jantoven? Tablets (Warfarin Sodium Tablets, USP) for oral use contain: 1 mg, 2 mg, 2? mg, 3 mg, 4 mg, 5 mg, 6 mg, 7?mg or 10 mg of crystalline warfarin sodium, USP. They also contain:

All Strengths: Lactose monohydrate, magnesium stearate, povidone, and pregelatinized starch (corn).

1 mg: FD&C Red #40 Aluminum Lake
2 mg: FD&C Blue #2 Aluminum Lake and FD&C Red #40 Aluminum Lake 2? mg: D&C Yellow #10 Aluminum Lake and FD&C Blue #1 Aluminum Lake
3 mg: Brown #75 Synthetic Brown Iron Oxide
4 mg: FD&C Blue #1 Aluminum Lake
5 mg: FD&C Yellow #6 Aluminum Lake
6 mg: Yellow #10 Synthetic Yellow Iron Oxide, Black #85 Synthetic Black Iron Oxide and FD&C Blue #1 Aluminum Lake 7? mg: D&C Yellow #10 Aluminum Lake and FD&C Yellow #6 Aluminum Lake
10 mg: Dye Free.

INDICATIONS

Jantoven? Tablets (Warfarin Sodium Tablets, USP) are indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism.

Jantoven? Tablets are indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement.

Jantoven? Tablets are indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

SIDE EFFECTS

Potential adverse reactions to Jantoven? Tablets (Warfarin Sodium Tablets, USP) may include:

* Fatal or nonfatal hemorrhage from any tissue or organ. This is a consequence of the anticoagulant effect. The signs, symptoms, and severity will vary according to the location and degree or extent of the bleeding. Hemorrhagic complications may present as paralysis paresthesia headache, chest, abdomen, joint, muscle or other pain dizziness shortness of breath, difficulty breathing or swallowing unexplained swelling weakness hypotension or unexplained shock. Therefore, the possibility of hemorrhage should be considered in evaluating the condition of any anticoagulated patient with complaints which do not indicate an obvious diagnosis. Bleeding during anticoagulant therapy does not always correlate with PT/INR. (See OVERDOSAGE: Treatment.)
* Bleeding which occurs when the PT/INR is within the therapeutic range warrants diagnostic investigation since it may unmask a previously unsuspected lesion, e.g., tumor, ulcer, etc.
* Necrosis of skin and other tissues. (See WARNINGS.)
* Adverse reactions reported infrequently include: hypersensitivity/allergic reactions, systemic cholesterol microembolization, purple toes syndrome, hepatitis, cholestatic hepatic injury, jaundice, elevated liver enzymes, hypotension, vasculitis, edema, anemia, pallor, fever, rash, dermatitis, including bullous eruptions, urticaria, angina syndrome, chest pain, abdominal pain including cramping, flatulence/bloating, fatigue, lethargy, malaise, asthenia, nausea, vomiting, diarrhea, pain, headache, dizziness, loss of consciousness, syncope, coma, taste perversion, pruritis, alopecia, cold intolerance, and paresthesia including feeling cold and chills.

Rare events of tracheal or tracheobronchial calcification have been reported in association with long-term warfarin therapy. The clinical significance of this event is unknown. Priapism has been associated with anticoagulant administration, however, a causal relationship has not been established.